The Antimicrobial Peptide Octopromycin Suppresses Biofilm Formation and Quorum Sensing in Acinetobacter baumannii. 2023

Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungnam National University, Daejeon 34134, Republic of Korea.

Acinetobacter baumannii is an opportunistic bacterial pathogen that causes severe infections in immunocompromised individuals. A. baumannii forms biofilm and produces extracellular matrix, which supports bacteria to survive under harsh conditions and be resistant to antibacterial treatments. In the present study, we investigated the biofilm and quorum-sensing inhibitory effects of antimicrobial peptide, octopromycin in A. baumannii. Field emission-scanning electron microscopy results clearly showed significantly reduced biofilm mass and caused a collapse in biofilm architecture at the minimum inhibitory concentration (50 µg/mL) and minimum bactericidal concentration (200 µg/mL) of octopromycin. Antibiotic-resistant persister cells of A. baumannii were successfully killed by octopromycin treatment, and it inhibited violacein production in Chromobacterium violaceum in a concentration-dependent manner. Octopromycin also inhibited alginate production, surface movements (swarming and swimming), and twitching motility of A. baumannnii, confirming its anti-quorum-sensing activity. Multiple metabolic pathways, two-component regulation systems, quorum-sensing, and antibiotic synthesis-related pathways in A. baumannii biofilms were strongly affected by octopromycin treatment. The collective findings indicate that the antibacterial peptide octopromycin may control A. baumannii biofilms through multi-target interactions. Octopromycin could be a desirable therapeutic option for the prevention and control of A. baumannii infections.

UI MeSH Term Description Entries

Related Publications

Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
March 2021, Journal of bacteriology,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
November 2020, Microbial pathogenesis,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
January 2018, International journal of molecular sciences,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
April 2013, Antimicrobial agents and chemotherapy,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
April 2014, The new microbiologica,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
January 1996, Microbios,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
January 2012, PloS one,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
January 2020, Frontiers in microbiology,
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
August 2014, Pathogens (Basel, Switzerland),
Dinusha Chathurangi Rajapaksha, and Shan Lakmal Edirisinghe, and Chamilani Nikapitiya, and Ilson Whang, and Mahanama De Zoysa
January 2023, Infection and drug resistance,
Copied contents to your clipboard!